莫沙必利与多潘立酮治疗功能性消化不良的临床效果对比

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Mosapride and Domperidone in the treatment of functional dyspepsia.Methods Altogether 90 patients with functional dyspepsia treated in our hospital from March 2016 to November 2017 were selected as study objects and they were divided into the Domperidone group (n=45)and the Mosapride group (n=45)according to the random number table method.The Domperidone group was given Domperidone,and the Mosapride group was given Mosapride.The control rate of functional dyspepsia,the scores of functional dyspepsia and life quality before and after treatment,the disappearance time of abdominal distension and hernia symptoms,the remission time of acid vomiting,and the rate of adverse drug reaction were compared between two groups.Results The total control effective rate of functional dyspepsia in the Mosapride group was higher than that in the Domperidone group,and the difference was statistically significant(P<0.05).There were no significant differences in the scores of functional dyspepsia and life quality before treatment between two groups(P>0.05).The scores of functional dyspepsia after treatment in two groups were lower than those before treatment,the scores of life quality were higher than those before treatment,and the differences were statistically significant(P<0.05).The score of functional dyspepsia after treatment in the Mosapride group was lower than that in the Domperidone group,the score of life quality was higher than that in the Domperidone group,and the differences were statistically significant(P<0.05).The disappearance time of abdominal distension and hernia symptoms,and the remission time of vomiting acid in the Mosapride group were shorter than those in the Domperidone group,and the differences were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between two groups(P>0.05).Conclusion The effect of Mosapride in the treatment of functional dyspepsia is definite.It can significantly improve symptoms,significantly promote life quality of patients,and has no serious adverse reactions,which is safe and effective,and worthy of promotion and application.

Key words： Mosapride Domperidone Functional dyspepsia Clinical effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Chao-wei

Cite this article:

LI Chao-wei. Clinical effect comparison of Mosapride and Domperidone in the treatment of functional dyspepsia[J]. 中国当代医药, 2018, 25(24): 133-135.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I24/133

[1]	张海云，李建周.莫沙必利与多潘立酮治疗功能性消化不良的疗效比较[J].中国继续医学教育，2016，8（19）：179-180.
[3]	黄小娟.莫沙必利与多潘立酮治疗功能性消化不良的临床疗效比较[J].医学理论与实践，2015，28（10）：1325-1326.
[4]	黄小炎.莫沙必利与多潘立酮治疗功能性消化不良的临床效果比较[J].临床医学研究与实践，2017，2（31）：32-33.
[6]	张剑韧.莫沙必利与多潘立酮治疗功能性消化不良的对照研究[J].基层医学论坛，2017，21（32）：4578-4579.
[2]	Bang CS，Kim JH，Baik GH，et al.Mosapride treatment for functional dyspepsia：A meta-analysis[J].JGastroenterol Hepatol，2015，30（1）：28-42.
[5]	Polivanova TV，Smirnova OV，Gorbacheva NN，et al.Efficiency of very low doses of antibodies to s100 protein in the complex therapy of functional dyspepsia in children.[J].Bull Exp Biol Med，2015，159（3）：341-343.
[7]	Liu Q，Qi D，Kang J，et al.Efficacy of real-time PCR-based detection of Helicobacter pyloriinfection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection[J].Eur JGastroenterol Hepatol，2015，27（3）：221-225.
[8]	冯永军，王开民，任学琴，等.莫沙必利与多潘立酮治疗功能性消化不良的临床疗效及安全性比较[J].基层医学论坛，2017，21（13）：1607-1608.
[9]	李俊，戎晓敏.莫沙必利与多潘立酮对功能性消化不良患者的临床疗效比较[J].抗感染药学，2017，14（1）：159-161.
[10]	吴维新，林芳萍，刘华荣.用莫沙必利和多潘立酮治疗功能性消化不良的效果对比[J].当代医药论丛，2017，15（4）：95-96.
[11]	于榆林，王晶.莫沙必利、多潘立酮在功能性消化不良患者治疗中的应用比较[J].中西医结合心血管病电子杂志，2016，4（26）：76-77.
[12]	张卫华，朱刚剑.莫沙必利与多潘立酮治疗功能性消化不良的临床疗效比较[J].中国社区医师，2016，32（24）：49-50.
[13]	Tahara T，Shibata T，Okubo M，et al.Association between interleukin-1β and tumor necrosis factor-α polymorphisms and symptoms of dyspepsia[J].Mol Med Rep，2015，11（5）：3888-3893.
[14]	张艾.莫沙必利与多潘立酮治疗功能性消化不良的疗效比较[J].中国药物经济学，2018，13（1）：72-74.
[15]	张艳.莫沙必利与多潘立酮治疗功能性消化不良的疗效比较[J].当代医学，2017，23（32）：151-153.